# Hitoshi Sugiyama

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hitoshi-sugiyama/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,191 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 59 |
| i10-index | 231 |
| Last Known Institution | Okayama University |
| OpenAlex ID | https://openalex.org/A5018111506 |
| ORCID iD | 0000-0002-4127-6471 |
| Works | 662 |

## Researcher papers

- [Clostridium botulinum neurotoxin](https://scholariq.org/papers/clostridium-botulinum-neurotoxin/)
- [Apoptosis in glomerular sclerosis](https://scholariq.org/papers/apoptosis-in-glomerular-sclerosis/)
- [Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond.](https://scholariq.org/papers/botulinum-g-neurotoxin-cleaves-vamp-synaptobrevin-at-a-single-ala-ala-peptide/)
- [A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease](https://scholariq.org/papers/a-decreased-level-of-serum-soluble-klotho-is-an-independent-biomarker-associated/)
- [Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney](https://scholariq.org/papers/establishment-and-characterization-of-renal-progenitor-like-cells-from-s3/)
- [A common subunit structure in Clostridium botulinum type A, B and E toxins](https://scholariq.org/papers/a-common-subunit-structure-in-clostridium-botulinum-type-a-b-and-e-toxins/)
- [Tumstatin Peptide, an Inhibitor of Angiogenesis, Prevents Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy](https://scholariq.org/papers/tumstatin-peptide-an-inhibitor-of-angiogenesis-prevents-glomerular-hypertrophy/)
- [Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality](https://scholariq.org/papers/annual-dialysis-data-report-for-2018-jsdt-renal-data-registry-survey-methods/)
- [Clostridium botulinum neurotoxin.](https://scholariq.org/papers/clostridium-botulinum-neurotoxin-2/)
- [Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases](https://scholariq.org/papers/clinical-practice-guideline-for-renal-rehabilitation-systematic-reviews-and/)
- [Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry](https://scholariq.org/papers/demographic-clinical-characteristics-and-treatment-outcomes-of-immune-complex/)
- [A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan](https://scholariq.org/papers/a-nationwide-analysis-of-renal-and-patient-outcomes-for-adults-with-lupus/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Fluid Dynamics and Turbulent Flows](https://scholariq.org/topics/fluid-dynamics-and-turbulent-flows/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Heat Transfer Mechanisms](https://scholariq.org/topics/heat-transfer-mechanisms/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)

## Researcher university

- [Okayama University](https://scholariq.org/institutions/okayama-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.